Indivior Pharmaceuticals, Inc. (SPUN)
NASDAQ: SPUN · Real-Time Price · USD
36.28
+0.91 (2.57%)
At close: Nov 2, 2026

Indivior Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3051953193167741,102
Short-Term Investments
--194109-
Trading Asset Securities
----10-
Cash & Short-Term Investments
3051953204108931,102
Cash Growth
-31.46%-39.06%-21.95%-54.09%-18.97%28.44%
Accounts Receivable
273253254254220202
Other Receivables
13233-513
Receivables
286255287254225215
Inventory
14915316713511495
Prepaid Expenses
213431521418
Other Current Assets
3915224151314
Total Current Assets
8006528271,2661,2591,444
Property, Plant & Equipment
1871701391248595
Long-Term Investments
2728274198-
Other Intangible Assets
226137082
Long-Term Deferred Tax Assets
288323277288219105
Other Long-Term Assets
2826402838106
Total Assets
1,3321,2011,3161,7601,7691,832

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
284863393326
Accrued Expenses
701784715700584694
Current Portion of Long-Term Debt
4882918333
Current Portion of Leases
71010988
Current Income Taxes Payable
6327897
Other Current Liabilities
144111153138266
Total Current Liabilities
1,3019149241,2901,019804
Long-Term Debt
-290315237237239
Long-Term Leases
62232342936
Other Long-Term Liabilities
8573382390433550
Total Liabilities
1,3921,2991,6531,9511,7181,629

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
-6262686870
Additional Paid-In Capital
163112908887
Retained Earnings
-197-243-443-2951,3031,438
Comprehensive Income & Other
-26-29-46-52-1,328-1,312
Shareholders' Equity
-60-98-337-19151203
Total Liabilities & Equity
1,3321,2011,3161,7601,7691,832

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
501351375283277286
Net Cash (Debt)
-196-156-55127616816
Net Cash Growth
----79.38%-24.51%42.41%
Net Cash Per Share
-1.55-1.22-0.410.934.435.37
Filing Date Shares Outstanding
118.04125.07124.66136.35136.48140.49
Total Common Shares Outstanding
118125125136.53136.48140.49
Working Capital
-501-262-97-24240640
Book Value Per Share
-0.51-0.78-2.70-1.400.371.44
Tangible Book Value
-62-100-343-204-19121
Tangible Book Value Per Share
-0.53-0.80-2.74-1.49-0.140.86
Land
10311176655155
Machinery
717676778077
Construction In Progress
70643823--
SEC Filings: 10-K · 10-Q